HRT Financial LP's Form 4 filing
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · filed Jul 1, 2026
- Accession no.
- 0001475597-26-000123
- Filed
- Jul 1, 2026, 7:17 PM ET
- Trade date
- Jun 29-30, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $110.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| HRT Financial LPCIK 0001475597 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | PPurchaseAcquired | +25,836 | $3.44 | +$88,875.84 | 71,842 | Direct | |
| Jun 30, 2026 | Common Stock | PPurchaseAcquired | +6,755 | $3.23 | +$21,818.65 | 78,597 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.